Some biomarkers assessed in peripheral blood such as interleukin 8 (IL-8), tumor circulating DNA (cDNA) or CD8+ memory effector cytotoxic T cells have recently shown to assist in tracking immune response in different tumors like NSCLC cancer and melanoma [35,36,37]. This evidence concerns the gene CXCL8 and melanoma.